Raltegravir.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 131, doi. 10.2165/00003495-200868010-00009
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2008 AND VI 68 AND IP 1
Results: 9
1
2
Nonresponse to Treatment for Hepatitis C: Current Management Strategies.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 27, doi. 10.2165/00003495-200868010-00003
- By:
- Publication type:
- Article
3
Antiretroviral Therapy: Optimal Sequencing of Therapy to Avoid Resistance.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 43, doi. 10.2165/00003495-200868010-00004
- By:
- Publication type:
- Article
4
Diclofenac Sodium Injection (Dyloject: In Postoperative Pain.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 123, doi. 10.2165/00003495-200868010-00008
- By:
- Publication type:
- Article
5
Pharmacological Treatment of Early Multiple Sclerosis.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 73, doi. 10.2165/00003495-200868010-00005
- By:
- Publication type:
- Article
6
Parnaparin: A Review of its Use in the Management of Venous Thromboembolism, Chronic Venous Disease and Other Vascular Disorders.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 105, doi. 10.2165/00003495-200868010-00007
- By:
- Publication type:
- Article
7
Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 85, doi. 10.2165/00003495-200868010-00006
- By:
- Publication type:
- Article
8
Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: What is the Optimal Initiation Time for the Maximum Benefit?
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 1, doi. 10.2165/00003495-200868010-00001
- By:
- Publication type:
- Article
9
Antiepileptic Drug Development in Children: Considerations for a Revisited Strategy.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 17, doi. 10.2165/00003495-200868010-00002
- By:
- Publication type:
- Article